Literature DB >> 31644378

Antifungal and antiaflatoxigenic activity of rosemary essential oil (Rosmarinus officinalis L.) against Aspergillus flavus.

Natália da Silva Bomfim1,2, Cássia Yumie Kohiyama1, Lydiana Pollis Nakasugi1, Samuel Botião Nerilo3, Simone Aparecida Galerani Mossini1, Jéssica Cristina Zoratto Romoli1, Jane Martha Graton Mikcha4, Benício Alves de Abreu Filho5, Miguel Machinski1.   

Abstract

The increased risk to health by diverse pathologies, such as cancer, liver diseases, and endocrine alterations, caused by chemical residues in food, has led to the search for sustainable agricultural management alternatives, such as the use of essential oils for the development of natural and eco-friendly fungicides. The aim of this study was to evaluate the antifungal and antiaflatoxigenic activity of Rosmarinus officinalis L. essential oil (REO) against Aspergillus flavus Link. REO was obtained by hydrodistillation and its major components were identified as 1,8-cineole (eucalyptol, 52.2%), camphor (15.2%) and α-pinene (12.4%) by GC/MS and NMR. The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) were both 500 µg/mL. REO reduced the mycelial growth of A. flavus at a concentration of 250 µg/mL (15.3%). The results obtained from scanning electron microscopy (SEM) demonstrated a reduction in the size of conidiophores and in the thickness of hyphae in A. flavus caused by treatment with REO (250 µg/mL). The production of ergosterol and the biomass of mycelium were both reduced as the REO treatment concentration increased. The production of aflatoxins B1 and B2 was inhibited after treatment with 250 µg/mL REO, a concentration below the MIC/MFC, indicating that the antiaflatoxigenic effect of REO is independent of its antifungal effect and is likely due to its direct action upon toxin biosynthesis. The data demonstrated that REO may be used as an alternative to synthetic fungicides.

Entities:  

Keywords:  Aflatoxins; Rosmarinus officinalis; antifungal; antimycotoxigenic activity; essential oil

Mesh:

Substances:

Year:  2019        PMID: 31644378     DOI: 10.1080/19440049.2019.1678771

Source DB:  PubMed          Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess        ISSN: 1944-0057


  7 in total

Review 1.  Novel Antifungal Agents and Their Activity against Aspergillus Species.

Authors:  Roya Vahedi-Shahandashti; Cornelia Lass-Flörl
Journal:  J Fungi (Basel)       Date:  2020-10-09

Review 2.  Present scenarios and future prospects of herbal nanomedicine for antifungal therapy.

Authors:  Rahul Yadav; Madhulika Pradhan; Krishna Yadav; Anand Mahalvar; Homesh Yadav
Journal:  J Drug Deliv Sci Technol       Date:  2022-05-13       Impact factor: 5.062

Review 3.  Antibacterial, Antifungal, Antimycotoxigenic, and Antioxidant Activities of Essential Oils: An Updated Review.

Authors:  Aysegul Mutlu-Ingok; Dilara Devecioglu; Dilara Nur Dikmetas; Funda Karbancioglu-Guler; Esra Capanoglu
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

Review 4.  Biocontrol Potential of Essential Oils in Organic Horticulture Systems: From Farm to Fork.

Authors:  Yuru Chang; Philip F Harmon; Danielle D Treadwell; Daniel Carrillo; Ali Sarkhosh; Jeffrey K Brecht
Journal:  Front Nutr       Date:  2022-01-13

5.  Antifungal Activity of Polymethoxylated Flavonoids (PMFs)-Loaded Citral Nanoemulsion against Penicillium italicum by Causing Cell Membrane Damage.

Authors:  Long Guo; Yi Li; Xiaoxue Mao; Rui Tao; Boyun Tao; Zhiqin Zhou
Journal:  J Fungi (Basel)       Date:  2022-04-11

6.  Inhibition of Aspergillus Parasiticus Growth and Aflatoxins Production by Natural Essential Oils and Phenolic Acids.

Authors:  Susana Lorán; Juan José Carramiñana; Teresa Juan; Agustín Ariño; Marta Herrera
Journal:  Toxins (Basel)       Date:  2022-05-31       Impact factor: 5.075

7.  Effects of aflatoxin B1 on the submandibular salivary gland of albino rats and possible therapeutic potential of Rosmarinus officinalis: a light and electron microscopic study.

Authors:  Bassant Ashraf; Dahlia Ghazy; Mohamed Shamel
Journal:  F1000Res       Date:  2020-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.